The new semi-automated workflow is designed to increase yield, sensitivity, and throughput by delivering exponentially more target cfDNA and ctDNA for molecular assays with greater automation and reduced hands-on technician time.
Read More
Droplet digital PCR can detect covid-19 cases qPCR misses.
Read More
New survey results show strong support for this standby of cervical cancer screening.
Read More
Growth of RNA sequencing allows physicians and researchers to analyze a patient’s full genetic profile.
Read More
Illumina has established oncology partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to expand the reach of TruSight Oncology.
Read More